RT Journal Article
SR Electronic
T1 579-A Targeting the NANOG-CRY1 axis sensitizes immunotherapy-refractory tumors and enhances efficacy of T cell-based immunotherapy by reinvigorating the anti-tumor immunity cycle
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1802
OP A1802
DO 10.1136/jitc-2023-SITC2023.0579-A
VO 11
IS Suppl 2
A1 Son, Min Kyu
A1 Oh, Se Jin
A1 Kim, Tae Woo
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_2/A1802.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.